[go: up one dir, main page]

DE60035434D1 - Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken - Google Patents

Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken

Info

Publication number
DE60035434D1
DE60035434D1 DE60035434T DE60035434T DE60035434D1 DE 60035434 D1 DE60035434 D1 DE 60035434D1 DE 60035434 T DE60035434 T DE 60035434T DE 60035434 T DE60035434 T DE 60035434T DE 60035434 D1 DE60035434 D1 DE 60035434D1
Authority
DE
Germany
Prior art keywords
epitop
libraries
selection
binding compounds
library
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035434T
Other languages
English (en)
Other versions
DE60035434T2 (de
Inventor
Ton Logtenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Vaccines and Prevention BV
Original Assignee
Crucell Holand BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crucell Holand BV filed Critical Crucell Holand BV
Publication of DE60035434D1 publication Critical patent/DE60035434D1/de
Application granted granted Critical
Publication of DE60035434T2 publication Critical patent/DE60035434T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60035434T 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken Expired - Lifetime DE60035434T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99204561 1999-12-27
EP99204561 1999-12-27
PCT/NL2000/000941 WO2001048485A2 (en) 1999-12-27 2000-12-21 Selecting library members capable of binding to epitopes

Publications (2)

Publication Number Publication Date
DE60035434D1 true DE60035434D1 (de) 2007-08-16
DE60035434T2 DE60035434T2 (de) 2008-05-15

Family

ID=8241110

Family Applications (3)

Application Number Title Priority Date Filing Date
DE60035434T Expired - Lifetime DE60035434T2 (de) 1999-12-27 2000-12-21 Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
DE60033455T Expired - Lifetime DE60033455T2 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler Antikörper gegen Ep-CAM und dessen Verwendung in Krebstherapie
DE60038132T Expired - Lifetime DE60038132T2 (de) 1999-12-27 2000-12-21 Antikörper gegen Ep-Cam

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE60033455T Expired - Lifetime DE60033455T2 (de) 1999-12-27 2000-12-21 Menschlischer monoklonaler Antikörper gegen Ep-CAM und dessen Verwendung in Krebstherapie
DE60038132T Expired - Lifetime DE60038132T2 (de) 1999-12-27 2000-12-21 Antikörper gegen Ep-Cam

Country Status (11)

Country Link
US (2) US20030096225A1 (de)
EP (3) EP1242823B1 (de)
JP (1) JP2003518391A (de)
AT (3) ATE353920T1 (de)
AU (1) AU783148B2 (de)
CA (1) CA2396029A1 (de)
DE (3) DE60035434T2 (de)
DK (1) DK1479696T3 (de)
ES (1) ES2282797T3 (de)
NZ (2) NZ531590A (de)
WO (1) WO2001048485A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658924B2 (en) * 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
JP4433798B2 (ja) * 2002-04-17 2010-03-17 ロベルト クレア ウォークスルー突然変異誘発における「ドーピング」
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
SI1523496T1 (sl) 2002-07-18 2011-11-30 Merus B V Rekombinantno proizvajanje zmesi protiteles
EP2395017A3 (de) 2003-05-30 2012-12-19 Merus B.V. Entwurf und Verwendung von gepaarten unterschiedlichen Regionen von spezifisch bindenden Molekülen
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
CN102138869B (zh) * 2003-09-08 2013-05-01 纳幕尔杜邦公司 基于肽的用于毛发、皮肤和指甲的调理剂和着色剂
EP1737971B1 (de) 2004-01-20 2017-08-16 Merus N.V. Gemische bindender proteine
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
US9079942B2 (en) 2009-02-09 2015-07-14 Epitomics, Inc. CDR-anchored amplification method
GB0909904D0 (en) 2009-06-09 2009-07-22 Affitech As Product
US8293483B2 (en) 2009-09-11 2012-10-23 Epitomics, Inc. Method for identifying lineage-related antibodies
WO2013003624A2 (en) 2011-06-29 2013-01-03 Academia Sinica The capture, purification and release of biological substance using a surface coating
CA2791109C (en) 2011-09-26 2021-02-16 Merus B.V. Generation of binding molecules
EP2819695B1 (de) * 2012-03-02 2018-06-27 Academia Sinica Antikörper gegen epithelzelladhäsionsmoleküle (epcam) und anwendungsverfahren dafür
ES2743399T3 (es) 2012-04-20 2020-02-19 Merus Nv Métodos y medios para la producción de moléculas heterodiméricas similares a Ig
EP3126814B1 (de) 2014-04-01 2019-06-12 Academia Sinica Verfahren und system zur diagnose und prognose von krebs
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
WO2019213624A1 (en) * 2018-05-04 2019-11-07 The Regents Of The University Of California Spiked primers for enrichment of pathogen nucleic acids among background of nucleic acids
WO2021211510A2 (en) * 2020-04-13 2021-10-21 Affyimmune Therapeutics, Inc. Epcam antibody and car-t cells
EP4259285A4 (de) * 2020-12-09 2024-12-11 Affyimmune Therapeutics, Inc. Dualer chimärer antigenrezeptor gegen epcam und icam-1
WO2023174521A1 (en) 2022-03-15 2023-09-21 Genmab A/S Binding agents binding to epcam and cd137
WO2025056180A1 (en) 2023-09-15 2025-03-20 BioNTech SE Methods of treatment using agents binding to epcam and cd137 in combination with pd-1 axis binding antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6265150B1 (en) * 1995-06-07 2001-07-24 Becton Dickinson & Company Phage antibodies
CA2267139A1 (en) * 1996-10-08 1998-04-16 Ton Logtenberg Methods and means for selecting peptides and proteins having specific affinity for a target
US6787638B1 (en) * 1998-12-02 2004-09-07 Applied Molecular Evolution, Inc. Tumor specific human monoclonal antibodies and methods of use

Also Published As

Publication number Publication date
EP1273918A2 (de) 2003-01-08
ES2282797T3 (es) 2007-10-16
US7777010B2 (en) 2010-08-17
DE60038132D1 (de) 2008-04-03
EP1242823A2 (de) 2002-09-25
EP1242823B1 (de) 2007-07-04
JP2003518391A (ja) 2003-06-10
DE60035434T2 (de) 2008-05-15
DE60033455D1 (de) 2007-03-29
NZ520074A (en) 2004-04-30
AU783148B2 (en) 2005-09-29
WO2001048485A9 (en) 2002-09-06
DE60033455T2 (de) 2007-11-29
WO2001048485A3 (en) 2002-01-31
US20030096226A1 (en) 2003-05-22
EP1273918A3 (de) 2003-05-02
ATE366419T1 (de) 2007-07-15
WO2001048485A2 (en) 2001-07-05
ATE386747T1 (de) 2008-03-15
DK1479696T3 (da) 2007-05-07
EP1479696A1 (de) 2004-11-24
US20030096225A1 (en) 2003-05-22
AU3244701A (en) 2001-07-09
EP1479696B1 (de) 2007-02-14
CA2396029A1 (en) 2001-07-05
ATE353920T1 (de) 2007-03-15
EP1273918B1 (de) 2008-02-20
NZ531590A (en) 2006-01-27
DE60038132T2 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
DE60035434D1 (de) Auswahl von epitop-bindungsfähigen verbindungen aus bibliotheken
BR9808945B1 (pt) processamento de hidrocarbonetos gasosos.
WO2003061570A3 (en) Engineered binding proteins
DK1360500T3 (da) Fremgangsmåde til selektiv målretning
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
WO2003029458A3 (de) Verfahren zur herstellung von protein-bibliotheken und zur selektion von proteinen daraus
WO2003062402A3 (en) Use of collections of binding sites for sample profiling and other applications
SE9404166D0 (sv) Multifunctional surfaces
PT1001265E (pt) Frasco para amostras
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
EP1074173A4 (de) Ungekehrt freitragende federklammer.
MY140649A (en) Method for splitting a data stream
DK0988563T3 (da) Fremgangsmåde til sortering af seismiske data
WO2001038566A3 (en) Screening method for candidate drugs
TR199800604A3 (tr) Anti-fas antikorlari.
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
IS5620A (is) Greiningar aðferðir
AU2986395A (en) Method for screening compound libraries
AU2001235530A1 (en) Method for synthesising and immobilising nucleic acids on a silanized solid support
NL1020857A1 (nl) Werkwijze voor het vaststellen van een datacompressiewerkwijze.
NL194641B (nl) Werkwijze voor het verwijderen van waterstofsulfide uit een gas.
BR0007149A (pt) Sistema de telecarregamento de arquivos de dados em vários computadores embarcados a bordo de um veìculo automóvel
NL1000361C2 (nl) Inrichting voor het in werking stellen van een klinkorgaan van een patroon.
NL1026994A1 (nl) Informatiedrager met daarop opgeslagen een zoekinformatiebestand, werkwijze en reproductieinrichting voor het reproduceren van de informatiedrager.
WO2000073345A3 (en) Antibodies specific for mycobacterial polypeptides and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition